Home         Forums  

Go Back   Marrowforums > Treatments > Drugs and Drug Treatments
Register FAQ Search Today's Posts Mark Forums Read

Drugs and Drug Treatments ATG, Cyclosporine, Revlimid, Vidaza, Dacogen, ...

Reply
 
Thread Tools Search this Thread
  #1  
Old Sat Jan 25, 2014, 12:26 PM
Diver down Diver down is offline
Member
 
Join Date: Oct 2013
Location: Miami FL
Posts: 25
Preventing relapse after SCT in high risk MDS??

I understand some centers are using SC Vidaza to prevent relapse after SCT in high risk patients and there is currently a study with oral Vidaza.

Does anyone know of publications on these options or if there are any other drugs being studied post transplant?

Wife of Diver Down
Reply With Quote
  #2  
Old Sat Jan 25, 2014, 03:31 PM
DanL DanL is offline
Member
 
Join Date: Dec 2010
Location: Denver, CO
Posts: 590
I will send studies when I get home, but the three strategies my doctor spoke of last week wetter 1) donor lymphocyte infusion 2) vidaza and 3) reduction in immune suppressants. They have been using vidaza for about 2 years with high risk patients, in some cases before any relapse.
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
Reply With Quote
  #3  
Old Sat Jan 25, 2014, 05:04 PM
mausmish mausmish is offline
Member
 
Join Date: Mar 2010
Location: Maryland
Posts: 453
I had post-BMT Vidaza for 10 months, 5-day cycles subcutaneous injections, intended to help prevent relapse. So far, so good (knock wood). My transplant was at Johns Hopkins 11/30/2010. I was supposed to do 12 months but they thought it might be exacerbating GvHD so stopped at 10. I had no immunosuppressants (had post transplant cytoxan instead).
__________________
Karen, age 62, dx MDS RAEB-2 1/8/10: pancytopenia WBC 2.7k/Hgb 7.4/Hct 22.1/Plt 19k; complex cytogenetics -3,del(5)(q14q33),-6,+8,+mar,17% blasts. MUD BMT Johns Hopkins 11/30/10. Dx tongue cancer 8/31/12. ok now. blog mausmarrow.com

Last edited by mausmish : Sat Jan 25, 2014 at 05:49 PM.
Reply With Quote
  #4  
Old Sat Jan 25, 2014, 11:59 PM
DanL DanL is offline
Member
 
Join Date: Dec 2010
Location: Denver, CO
Posts: 590
Here are a couple of articles about the use of Vidaza and/or DLI for higher risk patients:

http://www.ncbi.nlm.nih.gov/pubmed/20672358

http://www.mdsbeacon.com/news/2011/0...er-transplant/
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Revlimid and High Risk MDS RAEB 2 - 18% Blasts Peachy MDS 21 Tue Mar 17, 2015 02:42 PM
Hello and High Risk MDS Advice JordanN MDS 20 Sun Nov 23, 2014 11:24 PM
Different treatments for high risk MDS stayinghopeful MDS 1 Thu Sep 20, 2012 12:54 PM
The lower risk MDS patient at risk of rapid progression akita MDS 0 Mon Dec 27, 2010 04:28 AM


All times are GMT -4. The time now is 06:59 AM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org